Medicine and Health Sciences Commons^™

The Implications Of Regional And National Demographic Projections For Future Gms Costs In Ireland Through To 2026, Aisling Conway Lenihan, Martin Keneally, Noel Woods, Andreas Thummel, Marie Ryan

Dept. of Management & Enterprise Publications

As the health services in Ireland have become more resource-constrained, pressure has increased to reduce public spending on community drug schemes such as General Medical Services (GMS) drug prescribing and to understand current and future trends in prescribing. The GMS scheme covers approximately 37% of the Irish population in 2011 and entitles them, inter alia, to free prescription drugs and appliances. This paper projects the effects of future changes in population, coverage, claims rates and average claims cost on GMS costs in Ireland.